Clinical-stage biotech company Syntara (ASX: SNT) has stepped into a transformative year with a renewed focus on drug development. Entering 2024, the Company took the “new year, new me” concept seriously, divesting its Pharmaxis mannitol business and rebranding as Syntara with new leadership to include high profile biotech experts that have commercialised drugs for Big
Read More
Time to vote this board out and make history, reads the clarion call of Shane Yeend, a major shareholder of the independent Aussie game developer Mighty Kingdom (ASX: MKL). Yeend is bringing shareholders together to vote out the current board in favour of a “no nonsense board with extensive track records of successful ASX turnarounds”
Read More
The XJO is expected to open lower this morning. The U.S was closed overnight. Yesterday we had basically the same session as Friday. We retook intraday losses to finish mildly in the red as we continued the sidewards march of consolidation. This morning we are expected to retest support around 7,480. With U.S futures remaining
Read More
Specialised industrial products provider Coventry Group (ASX: CYG) has announced notable financial results for the first half of FY24. Its group sales reached $185.3 million, reflecting a substantial 5.4% increase from the prior year. Unaudited EBITDA also demonstrated significant growth, rising by 18.1% to $9.8 million. These results are aligned with last month’s forecasted figures—H1
Read More
Smart lockers company TZ Limited (ASX: TZL), serving clients like Apple, JLL, adidas, NSW Health and more, has reported a positive net cash inflow from operating activities, totaling $775,000 in Q2 FY24. Key components of the operating cash flows included receipts of $5 million, coming to $8.8 million year to date. It also reported payments
Read More
Unveiling a string of good news to begin 2024, microbiome health company Biome (ASX: BIO) has announced the launch of its Activated Probiotics in major European health retail outlets starting January 2024. Key distributors are CLF in the UK and iiHealthfoods in Ireland, with funding for the expansion coming from Biome’s current working capital. What’s
Read More
